Skip to main content
Signal8
Chivukula Pad profile photo

Pad Chivukula

CIK: 0001727317

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcturus Therapeutics Holdings Inc. logo
ARCT

Arcturus Therapeutics Holdings Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Dec 17, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    54K shares-
  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Dec 16, 2024
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    60K shares-
  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Oct 15, 2024
    Sale(S)
    Direct
    12K shares at avg. $20.76$249K

1-3 of 3

About Chivukula Pad

Chivukula Pad (SEC CIK 0001727317) files insider reports with the SEC as Chief Scientific Officer & COO of Arcturus Therapeutics Holdings Inc. (ARCT).

Signal8 holds 3 ownership filings by Chivukula Pad, all Form 4s, filed between Oct 16, 2024 and Dec 19, 2025. Those filings report 3 transactions, from Oct 15, 2024 to Dec 17, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Chivukula Pad's filings is in SAN DIEGO, CA.

Recent filings by Chivukula Pad

  • Dec 17, 2025: Grant or award of ARCT derivative securities (Form 4, code A).
  • Dec 16, 2024: Grant or award of ARCT derivative securities (Form 4, code A).
  • Oct 15, 2024: Open-market sale of ARCT shares (Form 4, code S).

Other insiders filing for Arcturus Therapeutics Holdings Inc. (ARCT)

How to read Form 4 transaction codes